STOCK TITAN

Trio-Tech International - TRT STOCK NEWS

Welcome to our dedicated news page for Trio-Tech International (Ticker: TRT), a resource for investors and traders seeking the latest updates and insights on Trio-Tech International.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trio-Tech International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trio-Tech International's position in the market.

News
Rhea-AI Summary
Trio-Tech International (TRT) reported a rise in shareholders' equity to $7.58 per share from $7.22 per share. However, revenue decreased by 2% to $12.2 million in the second quarter of fiscal 2024. Operating income also declined to $677,000, and net income remained unchanged at $507,000. Cash and cash equivalents increased to $10.97 million, and shareholders' equity rose to $31.53 million. CEO S.W. Yong expressed optimism about the company's distribution and manufacturing segments, citing a 63% increase in distribution revenue.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.97%
Tags
-
Rhea-AI Summary
Trio-Tech International (NYSE MKT: TRT) announced financial results for the first quarter of fiscal 2024, reporting a 17% decrease in revenue to $9,966,000 from $11,939,000 for the first quarter of fiscal 2023. This decline was primarily due to lower revenue in the Company’s testing services and manufacturing segments. Gross margin also declined to 25% of revenue compared to 30% of revenue for last year’s first quarter. Net income for the first quarter of fiscal 2024 was $230,000, or $0.05 per diluted share, down from $882,000, or $0.21 per diluted share, for the first quarter of fiscal 2023. The company's cash and cash equivalents increased to $8,333,000, and shareholders’ equity increased to $29,655,000. CEO S.W. Yong expressed optimism about the future, expecting a significant recovery of distribution sales in fiscal 2024 and positioning the company as a value-added reseller.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.79%
Tags
-
Rhea-AI Summary
Trio-Tech International announces Q4 and FY 2023 results. Despite challenging conditions in the semiconductor industry, the company maintained solid operating margins, improved cash flow, and delivered a profitable quarter and year. Testing services revenue increased 18.8% for the year. However, demand for testing services softened in the second half of fiscal 2023. Backlog at June 30, 2023, was $17,437,000. Fiscal 2023 gross margin improved to 27.1% of revenue. Net income for fiscal 2023 was $1,544,000. Cash and cash equivalents at June 30, 2023, were $7,583,000. Shareholders' equity increased to $29,571,000.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.29%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.99%
Tags
none
Trio-Tech International

NYSE:TRT

TRT Rankings

TRT Stock Data

26.77M
2.52M
39.43%
16.05%
0.65%
Semiconductor and Related Device Manufacturing
Manufacturing
Link
United States
Van Nuys

About TRT

trio-tech international is headquartered in van nuys, california and listed in the new york stock exchange (nasdaq: trt). the company designs, manufactures and markets both front and back-end equipment and systems used in the testing and production of semiconductors. the company has geographical presence in the united state, singapore, malaysia, thailand and china. trio-tech international operates our business in four segments: manufacturing, testing services, equipment distribution, and real estate. in addition to our propriety products, we offer a one-stop service to customers through the distribution of complementary products from taiwan, europe and the united states., complete with design consultancy and value-added services.